Cadmium exposure in adults across Europe: Results from the HBM4EU Aligned Studies survey 2014-2020.


Journal

International journal of hygiene and environmental health
ISSN: 1618-131X
Titre abrégé: Int J Hyg Environ Health
Pays: Germany
ID NLM: 100898843

Informations de publication

Date de publication:
09 2022
Historique:
received: 15 07 2022
revised: 30 09 2022
accepted: 05 10 2022
pubmed: 21 10 2022
medline: 9 11 2022
entrez: 20 10 2022
Statut: ppublish

Résumé

The objectives of the study were to estimate the current exposure to cadmium (Cd) in Europe, potential differences between the countries and geographic regions, determinants of exposure and to derive European exposure levels. The basis for this work was provided by the European Human Biomonitoring Initiative (HBM4EU) which established a framework for alignment of national or regional HBM studies. For the purpose of Cd exposure assessment, studies from 9 European countries (Iceland, Denmark, Poland, Czech Republic, Croatia, Portugal, Germany, France, Luxembourg) were included and urine of 20-39 years old adults sampled in the years 2014-2021 (n = 2510). The measurements in urine were quality assured by the HBM4EU quality assurance/quality control scheme, study participants' questionnaire data were post-harmonized. Spatially resolved external data, namely Cd concentrations in soil, agricultural areas, phosphate fertilizer application, traffic density and point source Cd release were collected for the respective statistical territorial unit (NUTS). There were no distinct geographic patterns observed in Cd levels in urine, although the data revealed some differences between the specific study sites. The levels of exposure were otherwise similar between two time periods within the last decade (DEMOCOPHES - 2011-2012 vs. HBM4EU Aligned Studies, 2014-2020). The age-dependent alert values for Cd in urine were exceeded by 16% of the study participants. Exceedances in the different studies and locations ranged from 1.4% up to 42%. The studies with largest extent of exceedance were from France and Poland. Association analysis with individual food consumption data available from participants' questionnaires showed an important contribution of vegetarian diet to the overall exposure, with 35% higher levels in vegetarians as opposed to non-vegetarians. For comparison, increase in Cd levels due to smoking was 25%. Using NUTS2-level external data, positive associations between HBM data and percentage of cropland and consumption of Cd-containing mineral phosphate fertilizer were revealed, which indicates a significant contribution of mineral phosphate fertilizers to human Cd exposure through diet. In addition to diet, traffic and point source release were identified as significant sources of exposure in the study population. The findings of the study support the recommendation by EFSA to reduce Cd exposure as also the estimated mean dietary exposure of adults in the EU is close or slightly exceeding the tolerable weekly intake. It also indicates that regulations are not protecting the population sufficiently.

Identifiants

pubmed: 36265402
pii: S1438-4639(22)00133-X
doi: 10.1016/j.ijheh.2022.114050
pii:
doi:

Substances chimiques

Cadmium 00BH33GNGH
Fertilizers 0
Phosphates 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

114050

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier GmbH.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare no conflict of interest.

Auteurs

Janja Snoj Tratnik (J)

Jožef Stefan Institute, Department of Environmental Sciences, Jamova cesta 39, 1000, Ljubljana, Slovenia. Electronic address: janja.tratnik@ijs.si.

David Kocman (D)

Jožef Stefan Institute, Department of Environmental Sciences, Jamova cesta 39, 1000, Ljubljana, Slovenia.

Milena Horvat (M)

Jožef Stefan Institute, Department of Environmental Sciences, Jamova cesta 39, 1000, Ljubljana, Slovenia.

Anna-Maria Andersson (AM)

Department of Growth and Reproduction, Copenhagen University Hospital-Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark.

Anders Juul (A)

Department of Growth and Reproduction, Copenhagen University Hospital-Rigshospitalet, Blegdamsvej 9, 2100, Copenhagen, Denmark.

Eva Jacobsen (E)

Faculty of Food Science and Nutrition, School of Health Science, University of Iceland, Aragata 14, IS-107, Reykjavik, Iceland.

Kristin Ólafsdóttir (K)

Department of Pharmacology and Toxicology, University of Iceland, Hofsvallagata 53, IS-107, Reykjavík, Iceland.

Jana Klanova (J)

RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic.

Lenka Andryskova (L)

RECETOX, Faculty of Science, Masaryk University, Kotlarska 2, Brno, Czech Republic.

Beata Janasik (B)

Nofer Institute of Occupational Medicine, ul. św. Teresy od Dzieciątka Jezus 8, 91-348, Lodz, Poland.

Wojciech Wasowicz (W)

Nofer Institute of Occupational Medicine, ul. św. Teresy od Dzieciątka Jezus 8, 91-348, Lodz, Poland.

Natasa Janev Holcer (N)

Croatian Institute of Public Health, Division for Environmental Health, Rockefellerova 7, 10000, Zagreb, Croatia; Faculty of Medicine University of Rijeka, Department of Social Medicine and Epidemiology, Braće Branchetta 20/1, 51 000, Rijeka, Croatia.

Sónia Namorado (S)

Department of Epidemiology, National Institute of Health Dr. Ricardo Jorge, Av. Padre Cruz, 1649-016, Lisbon, Portugal.

Inês Coelho (I)

Department of Food and Nutrition, National Institute of Health Dr. Ricardo Jorge, Av. Padre Cruz, 1649-016, Lisbon, Portugal.

Loïc Rambaud (L)

Department of Environmental and Occupational Health, Santé publique France, 12 rue du Val d'Osne, 94415, Saint Maurice, France.

Margaux Riou (M)

Department of Environmental and Occupational Health, Santé publique France, 12 rue du Val d'Osne, 94415, Saint Maurice, France.

An Van Nieuwenhuyse (A)

Department Health Protection, Laboratoire National de Santé, Rue Louis Rech 1, 3555, Dudelange, Luxembourg.

Brice Appenzeller (B)

Department of Precision Health, Luxembourg Institute of Health, 1 A-B Rue Thomas Edison, 1445, Strassen, Luxembourg.

Marike Kolossa-Gehring (M)

German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany.

Till Weber (T)

German Environment Agency (UBA), Corrensplatz 1, 14195, Berlin, Germany.

Marta Esteban-López (M)

National Centre for Environmental Health, Instituto de Salud Carlos III, Carretera de Majadahonda a Pozuelo km.2, 28220, Majadahonda, Madrid, Spain.

Argelia Castaño (A)

National Centre for Environmental Health, Instituto de Salud Carlos III, Carretera de Majadahonda a Pozuelo km.2, 28220, Majadahonda, Madrid, Spain.

Liese Gilles (L)

VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400, Mol, Belgium.

Laura Rodriguez Marti (L)

VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400, Mol, Belgium.

Greet Schoeters (G)

VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400, Mol, Belgium.

Ovnair Sepai (O)

UK Health Security Agency, Radiation, Chemicals and Environment Division, Harwell, OX11 0RQ, UK.

Eva Govarts (E)

VITO Health, Flemish Institute for Technological Research (VITO), Boeretang 200, 2400, Mol, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH